BIOTIE THERAPIES
Biotie is a specialized drug development company focused on central nervous system and inflammatory diseases. It has several innovative small molecule and biological drug candidates at different stages of clinical development. Biotie's products address diseases with high unmet medical need and significant market potential, including addiction and a broad range of inflammatory conditions such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD). The most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development by licensing partner H. Lundbeck A/S.
BIOTIE THERAPIES
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1998-01-01
Address:
Finans, Nigde, Turkey
Country:
Turkey
Website Url:
http://www.biotie.com
Total Employee:
11+
Status:
Active
Contact:
+135822748900
Email Addresses:
[email protected]
Total Funding:
252.46 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Virginia Region GeoTrust SSL Symantec.cloud Microsoft SharePoint Server 2010
Similar Organizations
3Biotech
3Biotech is a medical and biological development company, focusing directly on the needs of clients.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aprea
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.
FermCom Bio-VNT
FermCom Bio-VNT is a research and development company focused on biotechnology and network applications.
Onco-NX
Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
RespiVert
Respivert is a small molecule drug discovery company for the treatment of chronic obstructive pulmonary diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Syntopix Group
Syntopix Group is a drug development company focused on prescription and over-the counter products for the treatment of common inflammatory.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
TPP Global Development
TPP Global Development is a preclinical stage drug development company focused on nervous system disorders, immunology, and oncology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-01-11 | Synosia Therapeutics | Synosia Therapeutics acquired by Biotie Therapies | N/A |
Official Site Inspections
http://www.biotie.com Semrush global rank: 5.64 M Semrush visits lastest month: 564
- Host name: ec2-3-82-161-243.compute-1.amazonaws.com
- IP address: 3.82.161.243
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Biotie Therapies"
Biotie Therapies - Crunchbase Company Profile & Funding
Biotie is a specialized drug development company focused on central nervous system and inflammatory diseases. It has several innovative small molecule and biological drug …See details»
www.biotie.com
Biotie Therapies Oy on lääkekehitysyhtiö, joka keskittyy hermoston ja immuunijärjestelmän sairauksien hoitoon.See details»
Biotie Therapies Management Team | Org Chart - RocketReach
Biotie Therapies Management Biotie is a biopharmaceutical company focused on products for neurodegenerative and psychiatric disorders. Biotie's development has delivered Selincro …See details»
Organization of the Board of Directors and Board committees
May 29, 2015 As announced by Biotie Therapies Corp. (the "Company" or "Biotie") on 29 May 2015, Biotie has completed the issuance of in total 220,400,001 convertible promissory notes …See details»
Biotie Therapies Corp. Management Team | Org Chart - RocketReach
The Biotie Therapies Corp. management team includes Michael Eison (Vice President Regulatory Affairs), Kathleen Martin (VP Project and Portfolio Management), and Kai Lähdesmäki (CBO). …See details»
Organization of the Board of Directors and Board committees
May 29, 2015 BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 29 May 2015 at 8.45 a.m. Organization of the Board of Directors and Board committees As announced by …See details»
Biotie Therapies Company Profile 2024: Valuation, …
Biotie Therapies General Information Description. Provider of drug development services designed for neurodegenerative and psychiatric disorders. The company's drug development services primarily focus on developing and …See details»
Biotie Therapies, Inc.(Acorda Therapeutics) Company
Biotie Therapies, Inc. offers therapeutic drug research and development services focusing on the treatment of neurological and psychiatric disorders. The company was formerly known as …See details»
Biotie - Company Profile - Tracxn
Nov 15, 2024 Biotie Therapies is a specialized drug development company focused primarily on products for neurodegenerative and psychiatric disorders. Biotie products includes Selincro …See details»
Biotie Therapies: Contact Details and Business Profile
Biotie is a biopharmaceutical company focused on products for neurodegenerative and psychiatric disorders. Biotie's development has delivered Selincro (nalmefene) for alcohol dependence, …See details»
Biotie Therapies - Funding, Financials, Valuation & Investors
Biotie is a specialized drug development company focused on the central nervous system and inflammatory diseases. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Biotie Therapies Corp. - Turku, Finland - bionity.com
Jul 22, 2015 Biotie is a drug development company focusing on dependence disorders, inflammatory diseases and thrombosis. The most advanced drugs in development are …See details»
Biotie Therapies - Company Profile & Staff Directory - ContactOut
Biotie is a biopharmaceutical company focused on products for neurodegenerative and psychiatric disorders. Biotie's development has delivered Selincro (nalmefene) for alcohol dependence, …See details»
Acorda Online Reports - Biotie Acquisition
In January 2016, we announced an agreement to acquire Biotie Therapies for approximately $363 million in cash. This transaction, when completed, will add promising assets to our clinical …See details»
Biotie Therapies - Products, Competitors, Financials, Employees ...
Biotie is a specialized drug development company focused on the development of drugs for neurodegenerative and psychiatric disorders (e.g. Parkinson's disease, Alzheimer's disease …See details»
Biotie Therapies - Overview, News & Similar companies - ZoomInfo
Biotie Therapies was a Finnish biotechnology and pharmaceutics company that was acquired by Acorda Therapeutics in January 2016. The company's rese arch and development was …See details»
Biotie Therapies-Biotie Therapies Corp.-企业详情-InvestGO数据库 …
Dec 31, 1997 查看医药魔方InvestGO®数据库Biotie Therapies的公司信息。Biotie Therapies（Biotie Therapies Corp.），公司简介：Biotie is a specialized drug development …See details»
Biotie - Company Profile - Tracxn
Biotie - Commercial Stage biotech company developing drugs against CNS disease.. Acquired by Acorda. Raised a total funding of $150M over 4 rounds from 12 investors. Biotie has 51 …See details»
biotie - Products, Competitors, Financials, Employees, …
Biotie develops natural and vegan cosmetics within the beauty and skincare industry. The company offers a range of products, including body care, skincare, and hair care items made …See details»